153 related articles for article (PubMed ID: 19429070)
1. PPARgamma stimulation promotes neurite outgrowth in SH-SY5Y human neuroblastoma cells.
Miglio G; Rattazzi L; Rosa AC; Fantozzi R
Neurosci Lett; 2009 Apr; 454(2):134-8. PubMed ID: 19429070
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons.
Di Daniel E; Mudge AW; Maycox PR
Bipolar Disord; 2005 Feb; 7(1):33-41. PubMed ID: 15654930
[TBL] [Abstract][Full Text] [Related]
3. PPARgamma stimulation promotes mitochondrial biogenesis and prevents glucose deprivation-induced neuronal cell loss.
Miglio G; Rosa AC; Rattazzi L; Collino M; Lombardi G; Fantozzi R
Neurochem Int; 2009 Dec; 55(7):496-504. PubMed ID: 19442697
[TBL] [Abstract][Full Text] [Related]
4. JNK pathway is required for retinoic acid-induced neurite outgrowth of human neuroblastoma, SH-SY5Y.
Yu YM; Han PL; Lee JK
Neuroreport; 2003 May; 14(7):941-5. PubMed ID: 12802179
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone promotes neurite outgrowth and mitochondrial function in N2A cells via PPARgamma pathway.
Chiang MC; Cheng YC; Chen HM; Liang YJ; Yen CH
Mitochondrion; 2014 Jan; 14(1):7-17. PubMed ID: 24370585
[TBL] [Abstract][Full Text] [Related]
6. Ligands for the peroxisome proliferator-activated receptor-gamma have inhibitory effects on growth of human neuroblastoma cells in vitro.
Valentiner U; Carlsson M; Erttmann R; Hildebrandt H; Schumacher U
Toxicology; 2005 Sep; 213(1-2):157-68. PubMed ID: 16009482
[TBL] [Abstract][Full Text] [Related]
7. Mevastatin-induced neurite outgrowth of neuroblastoma cells via activation of EGFR.
Evangelopoulos ME; Weis J; Krüttgen A
J Neurosci Res; 2009 Jul; 87(9):2138-44. PubMed ID: 19224573
[TBL] [Abstract][Full Text] [Related]
8. CyclinB2 and BIRC5 genes as surrogate biomarkers for neurite outgrowth in SH-SY5Y subclonal cells.
Oe T; Nagashima T; Muramoto M; Yamazaki T; Morikawa N; Okitsu O; Nishimura S; Aoki T; Katayama Y; Kita Y
Neuropharmacology; 2006 Jun; 50(8):1041-7. PubMed ID: 16574167
[TBL] [Abstract][Full Text] [Related]
9. Raf kinase inhibitor protein enhances neuronal differentiation in human SH-SY5Y cells.
Hellmann J; Rommelspacher H; Mühlbauer E; Wernicke C
Dev Neurosci; 2010 Mar; 32(1):33-46. PubMed ID: 19955695
[TBL] [Abstract][Full Text] [Related]
10. Suppression of proliferation and neurite extension of human neuroblastoma SH-SY5Y cells on immobilized Psathyrella velutina lectin.
Kitamura N; Ikekita M; Hayakawa S; Funahashi H; Furukawa K
J Neurosci Res; 2004 Feb; 75(3):384-90. PubMed ID: 14743451
[TBL] [Abstract][Full Text] [Related]
11. TorsinA negatively controls neurite outgrowth of SH-SY5Y human neuronal cell line.
Ferrari-Toninelli G; Paccioretti S; Francisconi S; Uberti D; Memo M
Brain Res; 2004 Jun; 1012(1-2):75-81. PubMed ID: 15158163
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide-induced neurite remodeling in human neuroblastoma SH-SY5Y cells implicates the Cdc42 GTPase and is independent of Ras-ERK pathway.
Alleaume C; Eychène A; Harnois T; Bourmeyster N; Constantin B; Caigneaux E; Muller JM; Philippe M
Exp Cell Res; 2004 Oct; 299(2):511-24. PubMed ID: 15350548
[TBL] [Abstract][Full Text] [Related]
13. Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
Oda T; Kume T; Izumi Y; Takada-Takatori Y; Niidome T; Akaike A
Eur J Pharmacol; 2008 Nov; 598(1-3):27-31. PubMed ID: 18835264
[TBL] [Abstract][Full Text] [Related]
14. The effect of benomyl on neurite outgrowth in mouse NB2A and human SH-SY5Y neuroblastoma cells in vitro.
McLean WG; Holme AD; Janneh O; Southgate A; Howard CV; Reed MG
Neurotoxicology; 1998; 19(4-5):629-32. PubMed ID: 9745922
[TBL] [Abstract][Full Text] [Related]
15. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits neurite outgrowth in differentiating human SH-SY5Y neuroblastoma cells.
Jung JE; Moon JY; Ghil SH; Yoo BS
Toxicol Lett; 2009 Jul; 188(2):153-6. PubMed ID: 19446249
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide-induced neuritogenesis in neuroblastoma SH-SY5Y cells involves SNAP-25.
Héraud C; Chevrier L; Meunier AC; Muller JM; Chadéneau C
Neuropeptides; 2008; 42(5-6):611-21. PubMed ID: 18617262
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid differentiated SH-SY5Y human neuroblastoma cells: an in vitro model to assess drug neurotoxicity.
Nicolini G; Miloso M; Zoia C; Di Silvestro A; Cavaletti G; Tredici G
Anticancer Res; 1998; 18(4A):2477-81. PubMed ID: 9703895
[TBL] [Abstract][Full Text] [Related]
18. IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells.
Pitulis N; Papageorgiou E; Tenta R; Lembessis P; Koutsilieris M
Anticancer Res; 2009 Jun; 29(6):2331-7. PubMed ID: 19528499
[TBL] [Abstract][Full Text] [Related]
19. Effects of a PPAR-gamma agonist, on growth factor and insulin stimulated endothelial cells.
Desouza CV; Gerety M; Hamel FG
Vascul Pharmacol; 2009; 51(2-3):162-8. PubMed ID: 19520186
[TBL] [Abstract][Full Text] [Related]
20. PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention.
Kim MK; Chae YN; Kim HS; Choi SH; Son MH; Kim SH; Kim JK; Moon HS; Park SK; Shin YA; Kim JG; Lee CH; Lim JI; Shin CY
Arch Pharm Res; 2009 May; 32(5):721-7. PubMed ID: 19471887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
